Posts

Showing posts from September, 2024

Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association

Image
interstitial lung disease :: Article Creator Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd ConferencesESMO Congress Oncology nurses should inform patients about adverse events and the signs of interstitial lung disease before treating their breast cancer with T-DXd. Before starting them on trastuzumab deruxtecan (T-DXd; Enhertu), oncology nurses should discuss the use of anti-emetics as well as the potential for hair loss and interstitial lung disease with their patients, explained Nancy U. Lin, MD. Lin is a professor of Medicine at Harvard Medical School and a medical oncologist at the Dana-Farber Cancer Institute in Boston. At the 2024 ESMO Congress, she discussed findings from the phase 3b/4 DESTINYBreast-12 trial, which showed that trastuzumab deruxtecan led to promising response rates and progression-free survival in patients with HER2-positive metastatic breast cancer—even in the presence of brain metast...

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Image
hepatopulmonary syndrome treatment :: Article Creator Havana Syndrome Study Halted As Review Finds Some Patients Were Coerced A long-term study of Havana Syndrome patients was shut down after a National Institute of Health (NIH) internal review board found participants who reported being pressured to join the research. The study had until now not found evidence linking the participants to the same symptoms and brain injuries. The internal investigation that halted the study was prompted by complaints from the participants about unethical practices. This comes after the intelligence community released an interim report last year concluding a foreign adversary is "very unlikely" to be behind the symptoms hundreds of U.S. Intelligence officers are experiencing, despite qualifying for U.S. Government funded treatment of their brain injuries. In a statement to Fox News an NIH spokesperson stated, "In March 2024, the National Institutes...

State-of-the-art evidence in the treatment of systemic sclerosis

Image
magnesium and blood pressure :: Article Creator Should You Take Magnesium And Vitamin D Together? Social media has leaned into the idea that magnesium and vitamin D should be taken together to get the most benefits of both, when it comes to things like reducing fatigue, maintaining insulin resistance, and supporting immune health. Is there truth behind the buzz? Some experts say that if you take both magnesium and vitamin D supplements, it may be most helpful to take magnesium before or with vitamin D, rather than after. (More on the specific benefits of each below.) "This is because getting enough magnesium may maximize the effect of vitamin D and reduce the potential adverse effects of vitamin D," says Qi Dai, MD, PhD, a professor of medicine at Vanderbilt University Medical Center who researches vitamin D. In other words, you might boost vitamin D absorption with magnesium, but you need adequate magnesium first. In one trial w...

Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association

Image
spots on lungs causes :: Article Creator 5 Signs Of Lung Cancer Even Nonsmokers Need To Know The chest isn't the only spot that might feel heavy or tight, Dr. Chiang says. "If it goes to the bone, maybe in one of your vertebrae, you can weaken that bone and sometimes you can be more susceptible to a fracture," she notes. As for how lung cancer pain might differ from, say, anxiety-related chest pressure, again, it can be hard to differentiate, both experts agreed. The main thing to look for? It's new—and not letting up. 3. You're strangely short of breath. Vassallo was super active before her lung cancer symptoms settled in. So when she started having issues with her breathing, it was particularly noticeable. "I'd go to martial arts classes and lift weights, still in pain and tiring out really quickly," she explains. "I was training for a half-marathon at the time, but I eventually had to stop—I couldn...

Case report: Pulmonary arterial hypertension in ENG-related hereditary hemorrhagic telangiectasia

Image
chronic pulmonary lung disease :: Article Creator

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management

Image
pulmonary trunk function :: Article Creator Trends In Organ Systems - Vertebrate Circulatory Systems Trends in organ systems - Vertebrate circulatory systems Trends in organ systems - Vertebrate circulatory systems The metabolic activity of any tissue is limited by its blood supply; the more active any organ, the more blood it needs and the more extensive its vascularization. The changes in metabolic activity associated with endothermy and the change from gill to lung respiration has led to changes in vertebrate circulatory systems. Circulatory systems In general, blood is pumped by heart to arteries -> arterioles -> capillaries. Capillaries come together to form venioles -> veins -> major venous trunks -> heart Veins between two capillary networks are portal systems. Closed circulatory system, but fluid constituents of blood leak out of capillaries and return to the heart by the second component of the circulatory ...

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Image
esc 2021 heart failure :: Article Creator Adherence To 2021 ESC Heart Failure Guidelines Differed Across Practices Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key therapies. A recent survey conducted by the European Society of Cardiology (ESC) revealed significant differences in the implementation of the 2021 heart failure guidelines across global health care settings, particularly in the use of guideline-directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF).1 Published in the European Journal of Heart Failure, the survey included responses from 457 cardiologists across 88 countries, with most being general cardiologists (54%), followed by heart failure specialists (19.4%), other cardiac specialists (18.9%), and noncardiac specialists (7.7%).2 Over half of the respondents (52.1%) used a combination of echocardiography and...